Loading…
Loading…
Lanxess AG (LXS.DE) is a German specialty chemicals company (€6.4 bn revenue, FY2024) organised into three segments: Consumer Protection (biocides, disinfectants, wood protection, insect repellents), Specialty Additives (flame retardants, lubricant additives, plasticizers), and Advanced Intermediates (building-block chemicals for pharma/agrochem, chromium oxide pigments, bromine and phosphorus chemistry).
Widely held, ~95% free float; GLEIF (LEI 529900PTLRE72EMYIJ77) reports no parent, consistent with a top-level DAX-tier public company. No shareholder holds a controlling stake; Causeway Capital Management Trust is the largest disclosed holder per German WpHG voting-rights notifications (10.08% Aug 2025, rising to 15.1% Nov 2025).
Named counterparties identified by open-source research and written only where a primary source states the relationship — never inferred from sector or co-mention. 1 customer-side. This is a partial view: it covers the relationships we could evidence, not the company's full supply base.
LANXESS's own press release describes a signed 'understanding' (not a binding supply contract) to supply lithium-rich brine from its El Dorado, Arkansas site to Standard Lithium's battery-grade lithium extraction, plus land lease/infrastructure support; details of the cooperation are stated as subject to ongoing negotiation, so this is a disclosed but preliminary counterparty relationship, not a confirmed offtake.
Scope. Absence of a counterparty here is not evidence that none exists — most commercial sourcing is confidential and never becomes public. Rows without a share figure mean no share was disclosed, not that the relationship is small.
Another tracked dossier names this company as a counterparty in its own sourced disclosure — this platform never wrote these rows on this company's own page, they are read here inverted from the dossier that disclosed them. This is a partial view: 984 additional named-counterparty rows across the corpus could not be matched to a tracked dossier by name at all (mostly non-Latin legal names), so the true count is higher than what renders here.
R&D cooperation announced Jan 2024 to develop European iron-oxide supply for IBU-tecs LFP battery cathode material -- both companies own press release.
Scope. This section is inverted evidence: each linked dossier wrote the original row about itself, describing its own relationship to this company. It is never a claim this company itself disclosed. Absence here is not evidence of no relationship — most of the corpus has no named-counterparty block at all yet.
This company sits on the supply side for 1 of its 3 materials — a restriction on those is a tailwind, not a headwind.
As a buyer, policy pressure across its consumed materials is flat.
Descriptive trend in official policy actions on this company’s materials — a policy-pressure trend, not a price or trading signal. No forward probability is implied. Direction is measured on actions we have discovered, and discovery lags events: where the recent window is too thin to support a calm reading, the row says coverage-limited instead of easing.
As a producer, policy pressure across its produced materials is flat.
Descriptive trend in official policy actions on this company’s materials — a policy-pressure trend, not a price or trading signal. No forward probability is implied. Direction is measured on actions we have discovered, and discovery lags events: where the recent window is too thin to support a calm reading, the row says coverage-limited instead of easing.
🇪🇺 EU accounts for 100% of severity-weighted pressure.